Trudeau M - Search Results

1

Time to disease recurrence in basal-type breast cancers: effects of tumor size and lymph node status.

Dent R, Hanna WM, Trudeau M, Rawlinson E, Sun P, Narod SA. Dent R, et al. Among authors: trudeau m. Cancer. 2009 Nov 1;115(21):4917-23. doi: 10.1002/cncr.24573. Cancer. 2009. PMID: 19691094 Free article.

2

A comparison of all-subset Cox and accelerated failure time models with Cox step-wise regression for node-positive breast cancer.

Chapman JA, Trudeau ME, Pritchard KI, Sawka CA, Mobbs BG, Hanna WM, Kahn H, McCready DR, Lickley LA. Chapman JA, et al. Among authors: trudeau me. Breast Cancer Res Treat. 1992;22(3):263-72. doi: 10.1007/BF01840839. Breast Cancer Res Treat. 1992. PMID: 1391992

3

The predictive value of ERICA in breast cancer recurrence. A univariate and multivariate analysis.

Hanna W, McReady DR, Chapman JW, Mobbs BG, Trudeau ME. Hanna W, et al. Among authors: trudeau me. Mod Pathol. 1993 Nov;6(6):748-54. Mod Pathol. 1993. PMID: 7508116

4

The standardization of estrogen receptors.

Chapman JA, Mobbs BG, Hanna WM, Sawka CA, Pritchard KI, Lickley HL, Trudeau ME, Ryan ED, Ooi TC, Sutherland DJ, et al. Chapman JA, et al. Among authors: trudeau me. J Steroid Biochem Mol Biol. 1993 May;45(5):367-73. doi: 10.1016/0960-0760(93)90005-h. J Steroid Biochem Mol Biol. 1993. PMID: 7684604

5

The Henrietta Banting Breast Centre database: a model for clinical research utilizing a hospital-based inception cohort.

Sawka CA, Pritchard KI, Lickley HL, Oldfield GA, Chapman JA, Allen GG, Mobbs BG, Hanna WM, Kahn H, Trudeau ME, et al. Sawka CA, et al. Among authors: trudeau me. J Clin Epidemiol. 1995 Jun;48(6):779-86. doi: 10.1016/0895-4356(94)00176-q. J Clin Epidemiol. 1995. PMID: 7769408

6

An investigation of cut-points for primary breast cancer oestrogen and progesterone receptor assays.

Chapman JW, Mobbs BG, McCready DR, Lickley HL, Trudeau ME, Hanna W, Kahn HJ, Sawka CA, Fish EB, Pritchard KI. Chapman JW, et al. Among authors: trudeau me. J Steroid Biochem Mol Biol. 1996 Mar;57(5-6):323-8. doi: 10.1016/0960-0760(95)00275-8. J Steroid Biochem Mol Biol. 1996. PMID: 8639468

7

Clinical behavior of untreated axillary nodes after local treatment for primary breast cancer.

Baxter N, McCready D, Chapman JA, Fish E, Kahn H, Hanna W, Trudeau M, Lickley HL. Baxter N, et al. Among authors: trudeau m. Ann Surg Oncol. 1996 May;3(3):235-40. doi: 10.1007/BF02306277. Ann Surg Oncol. 1996. PMID: 8726177

8

First-line treatment of metastatic breast cancer.

Trudeau ME. Trudeau ME. Anticancer Drugs. 1996 Aug;7 Suppl 2:9-12. Anticancer Drugs. 1996. PMID: 8862703 Clinical Trial.

9

An improved statistical approach: can it clarify the role of new prognostic factors for breast cancer?

Chapman JW, Murray D, McCready DR, Hanna W, Kahn HJ, Lickley HL, Trudeau ME, Mobbs BG, Sawka CA, Fish EB, Pritchard KI. Chapman JW, et al. Among authors: trudeau me. Eur J Cancer. 1996 Oct;32A(11):1949-56. doi: 10.1016/0959-8049(96)00232-8. Eur J Cancer. 1996. PMID: 8943680 Review.

10

Evaluation of HER-2/neu (erbB-2) status in breast cancer: from bench to bedside.

Hanna W, Kahn HJ, Trudeau M. Hanna W, et al. Among authors: trudeau m. Mod Pathol. 1999 Aug;12(8):827-34. Mod Pathol. 1999. PMID: 10463486 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

472 results

Search Page

Filters